TALPHERA, INC. Deferred Tax Assets, Operating Loss Carryforwards
TALPHERA, INC. (TLPH) had Deferred Tax Assets, Operating Loss Carryforwards of $63.73 million as of 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-23
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $63.73M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $90.14M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $88.84M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $84.33M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $63.73M 10-K · filed 2026-03-23 |
| 2024-12-31 | $90.14M 10-K · filed 2026-03-23 |
| 2023-12-31 | $88.84M 10-K · filed 2025-03-31 |
| 2022-12-31 | $84.33M 10-K · filed 2024-03-06 |
| 2021-12-31 | $75.45M 8-K · filed 2023-08-01 |
| 2020-12-31 | $65.27M 10-K · filed 2022-03-10 |
| 2019-12-31 | $52.36M 10-K · filed 2021-03-15 |
| 2018-12-31 | $39.08M 10-K · filed 2020-03-16 |
| 2017-12-31 | $31.06M 10-K · filed 2019-03-07 |
| 2016-12-31 | $36.22M 10-K · filed 2018-03-09 |
| 2015-12-31 | $30.29M 10-K · filed 2017-03-03 |
| 2014-12-31 | $42.33M 10-K · filed 2016-03-07 |
| 2013-12-31 | $36.28M 10-K · filed 2015-03-13 |
| 2012-12-31 | $35.73M 10-K · filed 2014-03-17 |
| 2011-12-31 | $32.65M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |